Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Qing'an Zeng"'
Autor:
Liguo Zhang, Zhen Qiao, Yinsheng Yao, Zhiqiang Li, Lingzhi Hu, Yinyan Mao, Xiuling Liu, Weirong Chen, Qing'an Zeng, Hong Zhao
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e27837- (2024)
However, it is still difficult for clinicians to establish prognostic stratifications and therapeutic strategies because of the lack of tools for predicting the survival of triple-negative breast cancer patients with liver metastases (TNBC-LM). Based
Externí odkaz:
https://doaj.org/article/311cf743c846405f81082146ac96c63c
Autor:
Yuqin Yang, Liguo Zhang, Wenjing Tian, Yijie Li, Qi Qin, Yinyan Mao, Xiuling Liu, Jiawei Hong, Lingzhi Hu, Qing’an Zeng, Qingling Zhang, Hong Zhao
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7951-7961 (2023)
Abstract Background Brain metastasis (BM) in triple‐negative breast cancer (TNBC) patients is associated with significant morbidity and mortality. In this research we aimed to develop a nomogram to predict the prognosis of TNBC patients with BMs (T
Externí odkaz:
https://doaj.org/article/d4c9128fe6174382a4e70389b107d209
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Background The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) is involved in various cancers and often functions through microRNAs. The pro-survival protein PTP1B is known to play important roles in cancer development. However,
Publikováno v:
Journal of Breast Cancer
Publikováno v:
Journal of Breast Cancer
Purpose Four and a half LIM protein 1 (FHL1) is involved in breast cancer (BC) development, but the regulatory mechanism involved remain unclear. In the present study, we examined the role of FHL1 in BC development. Methods The expression of FHL1, mi
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 92
Arpin, a negative regulator of the actin-related protein-2/3 (Arp2/3) complex, is downregulated and predicts poor prognosis in breast cancer patients. However, its biological relevance in breast cancer is still unclear. This study was conducted to in
Autor:
Binkui Li, Ruhai Zou, Yun Zheng, Jiliang Qiu, Wei He, Qing'an Zeng, Yadi Liao, Jingxian Shen, Qi-Jiong Li, Yunfei Yuan, Guihua Chen
Publikováno v:
Surgery. 158(5)
With recent improvements in operative techniques, many studies have reported that resection is safe for hepatocellular carcinoma (HCC) patients with portal hypertension (PHT). However, no direct evidence exists to compare resection with ablation in p
Autor:
Yun Zheng, Yijie Li, Pinzhu Huang, Yunfei Yuan, Binkui Li, Shengping Li, Jian Hong, Qing'an Zeng, Ruhai Zou, Jiliang Qiu, Xiang-Ming Lao
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 148 (2012)
BMC Cancer
BMC Cancer
Background The prolonged survival of individuals diagnosed with cancer has led to an increase in the number of secondary primary malignancies. We undertook to perform a definitive study to characterize and predict prognosis of multiple primary malign
Autor:
Yi Li, Jian Hong, Pinzhu Huang, Xiang-Ming Lao, Yunfei Yuan, Binkui Li, Jiliang Qiu, Shengping Li, Yun Zheng, Qing'an Zeng, Ruhai Zou
Publikováno v:
European journal of gastroenterologyhepatology. 24(5)
Patients with hepatocellular carcinoma (HCC) presenting with nonmicronodular or micronodular cirrhosis are usually treated by hepatectomy. The value of resection for patients with hepatitis B virus-related macronodular cirrhosis, however, remains unk